Izumi Ohno

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Andrew X. Zhu, Yoon‐Koo Kang, Chia‐Jui Yen et al. · The Lancet Oncology · 2019 · 1.7K citations

Medicine, Oncology, Pharmacology +13

Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study

Makoto Ueno, Masafumi Ikeda, Chigusa Morizane et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 332 citations

Medicine, Oncology, Chemotherapy +5

Anodic Oxidation of Reductants in Electroless Plating

Izumi Ohno, Osamu Wakabayashi, Shirō Haruyama · Journal of The Electrochemical Society · 1985 · 260 citations

Natural Sciences, Chemistry, Materials Science +17

Electrochemistry of electroless plating

Izumi Ohno · Materials Science and Engineering A · 1991 · 166 citations

Natural Sciences, Materials Engineering, Materials Science +12

Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer

Shuichi Mitsunaga, Masafumi Ikeda, Satoshi Shimizu et al. · British Journal of Cancer · 2013 · 154 citations · Full text

Medicine, Oncology, Pharmacology +17